Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-20-010608

President and CEO acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CARUSO JAMES V President and CEO 2020-02-03 Grant or award +100,000 $2.71 $271,000 100,000 D
Loading xslF345X03/tm206696d1_4.xml…